| Trial ID: | L0186 |
| Source ID: | NCT01617772
|
| Associated Drug: |
L-Carnitine
|
| Title: |
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis
|
| Acronym: |
NALCAT
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Steatohepatitis
|
| Interventions: |
Drug: Atorvastatin|Drug: L-Carnitine|Drug: Placebo
|
| Outcome Measures: |
improvement in liver stiffness|improvement in liver enzyme levels|Adverse drug events
|
| Sponsor/Collaborators: |
Tehran University of Medical Sciences
|
| Gender: |
All
|
| Age: |
40 Years to 60 Years ?? (Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
440
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
January 1, 2016
|
| Completion Date: |
December 2019
|
| Results First Posted: |
--
|
| Last Update Posted: |
May 11, 2018
|
| Locations: |
Pars Cohort Center, Shiraz, Fars, Iran, Islamic Republic of|Masoud Clinic, Tehran, Iran, Islamic Republic of
|
| URL: |
https://ClinicalTrials.gov/show/NCT01617772
|
